These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1019584)

  • 1. Fibrinolytic activity in wound secretions.
    Aberg M; Hedner U; Jacobsson S; Rothman U
    Scand J Plast Reconstr Surg; 1976; 10(2):103-5. PubMed ID: 1019584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on healing of Debrisan-treated wounds.
    Jacobsson S; Jonsson L; Rank F; Rothman U
    Scand J Plast Reconstr Surg; 1976; 10(2):97-101. PubMed ID: 1019590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric fibrinolysis.
    Nilsson IM; Bergentz SE; Hedner U; Kullenberg K
    Thromb Diath Haemorrh; 1975 Nov; 34(2):409-18. PubMed ID: 807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.
    Hasegawa H; Nagata H; Yamauchi M; Murakoshi T; Oguma Y; Takei H; Seya T; Murao M
    Jpn Heart J; 1982 May; 23(3):339-47. PubMed ID: 6178853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new principle for the cleansing of infected wounds.
    Jacobsson S; Rothman U; Arturson G; Ganrot K; Haeger K; Juhlin I
    Scand J Plast Reconstr Surg; 1976; 10(1):65-72. PubMed ID: 940987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic activity in burn wound exudates and comparison of fibrin degradation products and protease inhibitors in exudates and sera.
    Prager MD; Baxter CR; Hartline B
    J Burn Care Rehabil; 1994; 15(2):130-6. PubMed ID: 8195252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local treatment of post-traumatic infections with debrisorb].
    Hertz H; Scharf W; Wruhs O
    Aktuelle Traumatol; 1983 Jun; 13(3):120-3. PubMed ID: 6192694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Debrisan: an effective new wound cleanser.
    Morrison JD
    Scott Med J; 1978 Oct; 23(4):277-8. PubMed ID: 725579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextranomer: a review of its general properties and therapeutic efficacy.
    Heel RC; Morton P; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Aug; 18(2):89-102. PubMed ID: 385281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
    Van Leer C; Stutz M; Haeberli A; Geiser T
    Thromb Haemost; 2005 Dec; 94(6):1257-64. PubMed ID: 16411403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an in vitro fibrin clot model to evaluate fibrinolytic agents for wound care application.
    Viennet C; Laurensou C; Goydadin AC; Faivre B; Muret P; Humbert P
    J Wound Care; 2014 Feb; 23(2):66-7, 70, 72. PubMed ID: 24526082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen content in diabetic wounds.
    Wiman B; Lithner F
    Acta Med Scand Suppl; 1984; 687():75-6. PubMed ID: 6591763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextran sulfate-dependent fibrinolysis in whole human plasma.
    Miles LA; Rothschild Z; Griffin JH
    J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
    Tsuji K; Eguchi Y; Kodama M
    J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
    Neuss S; Schneider RK; Tietze L; Knüchel R; Jahnen-Dechent W
    Cells Tissues Organs; 2010; 191(1):36-46. PubMed ID: 19390164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beads of a dextran polymer for the local treatment of cutaneous ulcers.
    Pace WE
    J Dermatol Surg Oncol; 1978 Sep; 4(9):678-82. PubMed ID: 701588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
    Belousov IuB; Panchenko EP; Pivovarov VA; Nemiro VK
    Kardiologiia; 1979 Aug; 19(8):87-91. PubMed ID: 491364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen.
    Green KA; Almholt K; Ploug M; Rønø B; Castellino FJ; Johnsen M; Bugge TH; Rømer J; Lund LR
    J Invest Dermatol; 2008 Aug; 128(8):2092-101. PubMed ID: 18337830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifibrinolytic effect of heparin].
    Rozenfel'd MA; Leonova VB; Khavkina LS; Meshkov BB
    Biokhimiia; 1984 Oct; 49(10):1672-8. PubMed ID: 6240283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ; Aldridge JH
    Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.